UVE Financial Statements & Analysis
Complete financial statements for UVE including income statement, balance sheet, and cash flow statement. Analyze UVE's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
4.9% ↑
Net Income
210.5% ↑
Gross Margin
190.9% ↑
Operating Margin
173.8% ↑
Balance Sheet
Current Ratio
-77.2% ↓
Debt to Equity
-32.8% ↑
Asset Turnover
5.0% ↑
Cash Flow
Operating Cash Flow
177.7% ↑
Net Cash Flow
256.5% ↑
Free Cash Flow
190.1% ↑
Cash Flow to Debt
179.8% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 1.52B | 1.60B | 4.9% | |
| Gross Profit | 199.73M | 609.72M | 205.3% | |
| Operating Income | 84.61M | 243.07M | 187.3% | |
| Net Income | 58.93M | 182.95M | 210.5% | |
| EPS | 2.07 | 6.56 | 216.9% | |
| EBITDA | 96.50M | 256.56M | 165.9% | |
| Gross Margin | 13.14% | 38.21% | 190.9% | |
| Operating Margin | 5.56% | 15.23% | 173.8% | |
| Net Income Margin | 3.88% | 11.47% | 195.9% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.60B | 1.52B | 1.39B | — | — |
| Gross Profit | 609.72M | 199.73M | 190.94M | — | — |
| Operating Income | 243.07M | 84.61M | 88.35M | — | — |
| Net Income | 182.95M | 58.93M | 66.82M | — | — |
| EPS | 6.56 | 2.07 | 2.24 | — | — |
| EBITDA | 256.56M | 96.50M | 101.48M | — | — |
| Gross Margin | 38.21% | 13.14% | 13.72% | — | — |
| Operating Margin | 15.23% | 5.56% | 6.35% | — | — |
| Net Income Margin | 11.47% | 3.88% | 4.80% | — | — |
| R&D Expenses | 0 | 0 | 0 | — | — |
Financial Metrics
Want to dive deeper into UVE's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics
